Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 25.

Liu, Rong, Martin, Tracey Amanda, Jordan, Nicola, Ruge, Fiona, Ye, Lin and Jiang, Wen Guo 2016. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer. International Journal of Oncology 48 (6) , pp. 2488-2496. 10.3892/ijo.2016.3462
file

Martin, Tracey Amanda, Jordan, Nicola, Davies, E. L. and Jiang, Wen Guo 2016. Metastasis to bone in human cancer is associated with loss of occludin expression. Anticancer Research 36 (3) , pp. 1287-1294.

Liu, Rong, Martin, Tracey Amanda, Jordan, Nicola Jane, Ruge, Fiona, Ye, Lin and Jiang, Wen Guo 2015. Metastasis suppressor 1 expression in human ovarian cancer: the impact on cellular migration and metastasis. International Journal of Oncology 47 (4) , pp. 1429-1439. 10.3892/ijo.2015.3121

Martin, Tracey Amanda, Jordan, Nicola, Meyers, Isaac and Jiang, Wen Guo 2015. Comparison of blood brain barrier endothelia reveals a differential expression of tight junction proteins [Abstract]. Anticancer Research 35 (7) , pp. 4357-4358.

Liu, Rong, Jordan, Nicola, Martin, Tracey Amanda, Ruge, Fiona, Ye, Lin and Jiang, Wen Guo 2015. Metastasis suppressor 1 (MTSS1) expression in human ovarian cancer; the impact on cellular migration and metastasis [Abstract]. Anticancer Research 35 (7) , p. 4342.

Jordan, Nicola Jane, Dutkowski, Carol Mary, Barrow, Denise, Mottram, Huw James, Hutcheson, Iain Robert, Nicholson, Robert Ian, Guichard, Sylvie M. and Gee, Julia Margaret Wendy 2014. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Research 16 (1) , R12. 10.1186/bcr3604
file

Lazaro, Glorianne, Smith, Chris, Goddard, Lindy, Jordan, Nicola Jane, McClelland, Richard Andrew, Barrett-Lee, Peter, Nicholson, Robert Ian and Hiscox, Stephen Edward 2013. Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response. Endocrine Related Cancer 20 (5) , pp. 691-704. 10.1530/ERC-13-0019

Hiscox, Stephen Edward, Baruha, Bedanta, Smith, Chris, Bellerby, Rebecca, Goddard, Lindy, Jordan, Nicola Jane, Poghosyan, Zaruhi, Nicholson, Robert Ian, Barrett-Lee, Peter and Gee, Julia Margaret Wendy 2012. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer 12 , 458. 10.1186/1471-2407-12-458
file

Gee, Julia Margaret Wendy, Nicholson, Robert Ian, Barrow, Denise, Dutkowski, Carol Mary, Goddard, Lindy, Jordan, Nicola J., McClelland, Richard Andrew, Knowlden, Janice Mary, Francies, Hayley E., Hiscox, Stephen Edward and Hutcheson, Iain Robert 2011. Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance. Hormone Molecular Biology and Clinical Investigation 5 (2) , pp. 67-77. 10.1515/HMBCI.2011.009

Hiscox, Stephen Edward, Jordan, Nicola Jane, Smith, Chris, James, M., Morgan, Liam David, Taylor, Kathryn Mary, Green, T. P. and Nicholson, Robert Ian 2009. Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells. Breast Cancer Research and Treatment 115 (1) , pp. 57-67. 10.1007/s10549-008-0058-6

Hiscox, Stephen Edward, Jordan, Nicola Jane, Morgan, Liam David, Smith, Christopher, Goddard, Lindy, Gee, Julia Margaret Wendy and Nicholson, Robert 2009. Adverse features of acquired antihormone resistance and their targeting. In: Hiscox, Stephen Edward, Gee, Julia Margaret Wendy and Nicholson, Robert eds. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New Molecular Aspects and their Potential as Targets, London: Springer, pp. 139-160. (10.1007/978-1-4020-8526-0_8)

Baruah, Bedanta Prakash, Smith, Chris, Jordan, Nicola Jane, Nicholson, Robert Ian, Robertson, Jane, Barrett-Lee, Peter and Hiscox, Stephen Edward 2009. Overexpression of CD44 in acquired endocrine resistant breast cancer modulates erbB activity and promotes an invasive phenotype. Cancer Research 69 (2) , 811S-811S.

Hiscox, Stephen Edward, Jordan, Nicola Jane, Crandon-Lewis, A., Jiang, W., Nicholson, Robert Ian and Gee, Julia Margaret Wendy 2009. Overexpression of L1CAM accompanies acquired endocrine resistance and is associated with the development of an aggressive cell phenotype [Abstract]. Cancer Research 69 (2) , 213S-213S. 10.1158/0008-5472.SABCS-3028

Taylor, Kathryn Mary, Vichova, Petra, Jordan, Nicola Jane, Hiscox, Stephen Edward, Hendley, Rhiannon and Nicholson, Robert Ian 2008. ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cells. Endocrinology 149 (10) , pp. 4912-4920. 10.1210/en.2008-0351

Hiscox, Stephen Edward, Goddard, Lindy, Jordan, Nicola Jane, Smith, Chris, Harper, Maureen Elaine, Nicholson, Robert Ian and Gee, Julia Margaret Wendy 2008. Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1 [Abstract]. Breast Cancer Research 10 (S2) , P34. 10.1186/bcr1918
file

Taylor, Kathryn Mary, Jordan, Nicola JAne, Hiscox, Stephen Edward, Gee, Julia Margaret Wendy and Nicholson, Robert Ian 2008. Zinc transporter HKE4 as a new target in antihormone resistance of breast cancer [Abstract]. Breast Cancer Research 10 (s2) , P42. 10.1186/bcr1926
file

Hiscox, Stephen Edward, Green, T. P., Smith, Chris, James, M., Jordan, Nicola Jane and Nicholson, Robert Ian 2007. Combination treatment with AZD0530 and tamoxifen prevents acquired antiestrogen resistance in breast cancer cells [Abstract]. Molecular Cancer Therapeutics 6 (Suppl) , 3411S.

Hiscox, Stephen Edward, Jordan, Nicola Jane, Morgan, Liam David, Green, T. P. and Nicholson, Robert Ian 2007. Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clinical & Experimental Metastasis 24 (3) , pp. 157-167. 10.1007/s10585-007-9065-y

Khirwadkar, Yamini, Hiscox, Stephen Edward, Jordan, Nicola Jane and Nicholson, Robert Ian 2007. HGF/SF promotes an aggressive phenotype in c-Met-overexpressing fulvestrant-resistant MCF-7 cells - Evidence for MMP-9 and PI3k involvement [Abstract]. Annals of Oncology 18 (S4) , P611. 10.1093/annonc/mdm166

Hiscox, Stephen Edward, Jordan, Nicola Jane, Jiang, Wen Guo, Harper, Maureen Elaine, McClelland, Richard, Smith, Chris and Nicholson, Robert 2006. Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions. Endocrine-Related Cancer 13 (4) , pp. 1085-1099. 10.1677/erc.1.01270

Jordan, Nicola Jane, Gee, Julia Margaret Wendy, Barrow, Denise, Wakeling, A. E. and Nicholson, Robert Ian 2004. Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Research and Treatment 87 (2) , pp. 167-180. 10.1023/B:BREA.0000041623.21338.47

Nicholson, Robert, Hutcheson, Iain Robert, Knowlden, Janice Mary, Jones, Helen E., Harper, Maureen Elaine, Jordan, Nicola Jane, Hiscox, Stephen Edward, Barrow, Denise and Gee, Julia Margaret Wendy 2004. Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination. Clinical Cancer Research 10 (1) , 346s-354s. 10.1158/1078-0432.CCR-031206

Nicholson, Robert, Hutcheson, Iain Robert, Knowlden, Janice Mary, Britton, David James, Harper, Maureen Elaine, Jordan, Nicola Jane, Hiscox, Stephen Edward, Barrow, Denise and Gee, Julia Margaret Wendy 2004. Chapter 16: beyond antihormones in the targeted therapy of breast cancer. In: Ingle, James N. and Dowsett, Mitchell eds. Endocrine Therapy for Breast Cancer Proceedings of the 2003 Gleneagles Conference, New York: Marcel Dekker, pp. 249-258.

Gee, Julia Margaret Wendy, Harper, Maureen Elaine, Hutcheson, Iain Robert, Madden, Tracie-Ann, Barrow, Denise, Knowlden, Janice Mary, McClelland, Richard Andrew, Jordan, Nicola Jane, Wakeling, A. E. and Nicholson, Robert Ian 2002. ZD1839 ('Iressa') improves the antitumour activity of tamoxifen ('Nolvadex') and ICI 182, 780 ('Faslodex') in antihormone responsive breast cancer [Abstract]. European Journal of Cancer 38 (S7) , S59. 10.1016/S0959-8049(02)80835-8

Nicholson, Robert Ian, Harper, Maureen Elaine, Hutcheson, Iain Robert, Madden, Tracie-Ann, Barrow, Denise, Knowlden, Janice Mary, Jordan, Nicola Jane, Wakeling, A. E. and Gee, Julia Margaret Wendy 2001. ZD1839 (Iressa) improves the antitumor activity of tamoxifen (Nolvadex) in antihormone-responsive breast cancer cells [Abstract]. Clinical Cancer Research 7 (S) , 3766S.

This list was generated on Thu Jul 18 04:13:53 2019 BST.